
Sidley represented Dechra, a global leader in veterinary specialty care, in its acquisition of Gallant Pet Inc., a U.S.-based animal health biotechnology company pioneering off-the-shelf mesenchymal stromal cell (MSC) therapies for pets. The acquisition expands Dechra’s portfolio into regenerative medicine, adding an innovative therapeutic platform with the potential to address unmet medical needs and broaden treatment options for chronic and complex conditions in companion animals.
The Sidley team was led by Chris Boyle (Food, Drug and Medical Device), Rosemary Reilly (Emerging Companies and Venture Capital), and Emily Hunter (Private Equity); and included Elina Sigal (Private Equity); Adriana Tibbitts, Karena Kong, and Patrick Donaldson (Technology and Life Sciences Transactions); Sarah Wiley and Adrianna Ramirez Mateo (M&A); Emily Marden and Kevin Sforza (Food, Drug and Medical Device); Eric Wolf and Ryan McLeod (Employee Benefits and Executive Compensation); Christian Brause and Daniel Venetucci (Tax); Amy Mahan (IP Litigation); Ryan Mulligan (White Collar Defense and Investigations); Stephen McInerney (Privacy and Cybersecurity); and Eric Kauffman (Labor, Employment and Immigration).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record

